G
Power Law company profile
GenMark Diagnostics
Biotech & Life Sciences · Carlsbad, United States · Founded 2010 · IPO 2010 Unicorn
Valuation
$1.80B
Market cap · 2026
Revenue
$213M
Latest reported FY
Global footprint
Where GenMark Diagnostics has talent and traffic
AI talent share
0.7%
of workforce is AI talent
(3 of 434 staff)
(3 of 434 staff)
Core AI00%
Other AI30.69%
Non-AI workforce43199.31%
Patent intelligence
$38M patent portfolio · 23 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$38M
2.1% of market cap · 72.4× smaller than top peer Illumina ($2.7B)
23 active patent families
Where GenMark Diagnostics innovates
AnalyteBiologyNucleic acidElectrochemical detectionFluidics
Above peer median on Legal, Strategic, Market
Quality vs same-sector peers
GenMark Diagnostics on the five Patsnap quality dimensions
GenMark Diagnostics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where GenMark Diagnostics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across GenMark Diagnostics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee GenMark Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.